Ansan-si, South Korea

Yeong-Taek Park




Average Co-Inventor Count = 4.9

ph-index = 1

Forward Citations = 58(Granted Patents)


Location History:

  • Gyeonggi-Do, KR (2011)
  • Ansan-si, KR (2020 - 2021)

Company Filing History:


Years Active: 2011-2021

Loading Chart...
Loading Chart...
Loading Chart...
5 patents (USPTO):

Title: Yeong-Taek Park: Innovator in Pharmaceutical Compositions

Introduction

Yeong-Taek Park is a notable inventor based in Ansan-si, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the development of oral compositions that incorporate taxanes. With a total of five patents to his name, Park's work is recognized for its innovative approaches to drug formulation.

Latest Patents

Among his latest patents, Park has developed a pharmaceutical composition for oral administration that includes a taxane, medium chain triglycerides, and an oleoyl glycerol complex. This composition is designed to enhance the bioavailability of taxanes, which are crucial in cancer treatment. Another significant patent involves a high concentration taxane formulation, which comprises a specific percentage of taxane, medium chain triglycerides, monooleoyl glycerol, surfactants, and polyoxyl glyceryl fatty acid esters. These inventions aim to improve the effectiveness and ease of administration of taxane-based therapies.

Career Highlights

Throughout his career, Yeong-Taek Park has worked with reputable companies in the pharmaceutical industry, including Dae Hwa Pharma Co., Ltd. and Daehwa Pharm Co., Ltd. His experience in these organizations has allowed him to refine his expertise in drug formulation and development.

Collaborations

Park has collaborated with notable colleagues such as In-Hyun Lee and Min-Hee Son. These partnerships have contributed to the advancement of his research and the successful development of his patented compositions.

Conclusion

Yeong-Taek Park's innovative work in pharmaceutical compositions showcases his dedication to improving drug delivery systems. His contributions are vital in the ongoing efforts to enhance cancer treatment options through effective oral formulations.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…